About 1 300 reports

eClinical Solutions Market by Product, Delivery Mode, Clinical Trial Phases, End User - Global Forecast to 2020

161 pages • By MarketsandMarkets

The global eClinical solutions market is estimated to grow at a high CAGR of 12.1% from 2015 to 2020. Although developed regions (such as North America and Europe) held large shares in the eClinical solutions market in 2015, the Asia-Pacific region is poised to grow at the highest CAGR of 16.1% in the next five years. Factors such as the increasing...

3 720 4 650 2 976
Feb 2016

Proteomics GLOBAL Industry report

150 pages • By Plimsoll Publishing Ltd UK

Plimsoll’s Proteomics (GLOBAL) analysis is the most definitive and accurate study of the Proteomics (GLOBAL) sector in 2015.The report is split into two sections and uses both a written and graphical analysis – analysing the 92 largest Proteomics (GLOBAL) companies. The Proteomics (GLOBAL) report contains the most-up-to-date...

1 188 1 294 950
Feb 2016

Clinical Research UK Industry report

260 pages • By Plimsoll Publishing Ltd UK

Plimsoll’s Clinical Research (UK) analysis is the most definitive and accurate study of the Clinical Research (UK) sector in 2015.The report is split into two sections and uses both a written and graphical analysis – analysing the 95 largest Clinical Research (UK) companies. The Clinical Research (UK) report contains the most-up-to-date...

438 477 350
Feb 2016

Clinical Research Organization NORDIC Industry report

130 pages • By Plimsoll Publishing Ltd UK

Plimsoll’s Clinical Research Organization (NORDIC) analysis is the most definitive and accurate study of the Clinical Research Organization (NORDIC) sector in 2015.The report is split into two sections and uses both a written and graphical analysis – analysing the 72 largest Clinical Research Organization (NORDIC) companies. The...

713 777 570
Feb 2016

Label-Free Detection Market by Technology, Products, Applications - Global Forecasts to 2020

146 pages • By MarketsandMarkets

The global label free detection market is valued at USD 1.22 billion in 2015 and expected to reach USD 2.13 billion by 2020, at a CAGR of 11.86% from 2015 to 2020. Label-free technology is rapidly gaining widespread acceptance as a drug discovery and life science research tool. Currently, the drug discovery process is based on target identification...

3 720 4 650 2 976
Jan 2016

ShangPharma – Qidong Pre-clinical Research Facility – Jiangsu - Construction Project Profile

7 pages • By Timetric

SynopsisThe "ShangPharma – Qidong Pre-clinical Research Facility – Jiangsu - Construction Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering...

60 75 48
Jan 2016

Analysis of the Global Mass Spectrometry Market 

121 pages • By Frost & Sullivan

Analysis of the Global Mass Spectrometry Market : Emerging Technologies Empower ScientistsThis research service analyzes the global mass spectrometry market. The product segments covered include single quadrupole LC-MS, tandem quadrupole LC-MS, GC-MS, TOF LC-MS, ICP-MS, and MALDI-TOF MS. End-user groups have been divided into the academia...

4 800 6 000 3 840
Jan 2016

Drug Discovery Outsourcing Global Market – Forecast To 2022

182 pages • By IQ4I Research & Consultancy Pvt. Ltd

Over the last two decades, the Pharmaceutical/Biotech industry has undergone radical changes. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift towards biologics have seen a surge in the externalization and outsourcing activities. As the industry is looking for new sources of discovery...

12 000 15 000 9 600
Jan 2016

Global CRISPR Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And Forecast 2015 – 2021

140 pages • By Occams

Clustered regularly-interspaced short palindromic repeats also known as CRISPR is a gene editing tool. CRIPSR commercialization began in 2012 with emergence of number of startups and venture capitalists and showing their interest in infusing money into this technology. Academic and research firms are the main consumers of CRISPR gene editing...

3 200 4 000 2 560
Jan 2016

Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2015

342 pages • By Global Data

Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2015SummaryGlobalData's Medical Devices sector report, “Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Cardiovascular Surgery Devices currently in pipeline stage.The report provides comprehensive...

3 200 4 000 2 304
Jan 2016

Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015

295 pages • By Global Data

Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015SummaryGlobalData's Medical Devices sector report, “Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015" provides an overview of Auto-Immune Diseases currently in pipeline stage.The report provides comprehensive information on the pipeline...

3 200 4 000 2 304
Jan 2016

Aesthetic Devices - Medical Devices Pipeline Assessment, 2015

313 pages • By Global Data

Aesthetic Devices - Medical Devices Pipeline Assessment, 2015SummaryGlobalData's Medical Devices sector report, “Aesthetic Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Aesthetic Devices currently in pipeline stage.The report provides comprehensive information on the pipeline products...

3 200 4 000 2 304
Jan 2016

Neurological Diagnostic Equipment - Medical Devices Pipeline Assessment, 2015

266 pages • By Global Data

Neurological Diagnostic Equipment - Medical Devices Pipeline Assessment, 2015SummaryGlobalData's Medical Devices sector report, “Neurological Diagnostic Equipment - Medical Devices Pipeline Assessment, 2015" provides an overview of Neurological Diagnostic Equipment currently in pipeline stage.The report provides...

3 200 4 000 2 304
Jan 2016

Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2015

265 pages • By Global Data

Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2015SummaryGlobalData's Medical Devices sector report, “Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2015" provides an overview of Immunochemistry Analyzers currently in pipeline stage.The report provides comprehensive information...

3 200 4 000 2 304
Jan 2016

Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015

216 pages • By Global Data

Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015SummaryGlobalData's Medical Devices sector report, “Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage.The report provides comprehensive information...

3 200 4 000 2 304
Jan 2016

Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2015

323 pages • By Global Data

Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2015SummaryGlobalData's Medical Devices sector report, “Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Cardiac Assist Devices currently in pipeline stage.The report provides comprehensive information on...

3 200 4 000 2 304
Jan 2016

Respiratory Devices - Medical Devices Pipeline Assessment, 2015

459 pages • By Global Data

Respiratory Devices - Medical Devices Pipeline Assessment, 2015SummaryGlobalData's Medical Devices sector report, “Respiratory Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Respiratory Devices currently in pipeline stage.The report provides comprehensive information on the pipeline...

3 200 4 000 2 304
Jan 2016

Global E-Clinical Solution Market Size, Share, Development, Growth and Demand Forecast to 2020 – Industry Insights by Type (Products, Professional Services), by Products (CTMS, EDC/ CDMS, Safety Solution, eCOA Solution, RTSM Solution), by Delivery Mode (W

147 pages • By P&S Market Research

The global e-clinical solution market accounted for $2,997.0 million value in 2014, and it is expected to grow with a CAGR of 13.7% during 2015-2020. Among the various delivery modes, the web based e-clinical solution segment dominated the global e-clinical solution market, with 72.7% share in 2014. Moreover, among the various end users, the...

3 600 4 500 2 880
Jan 2016

Xerostomia-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Xerostomia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Xerostomia. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 000 1 250 800
Jan 2016

Pouchitis-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Pouchitis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Pouchitis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 000 1 250 800
Jan 2016

Sarcoidosis-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Sarcoidosis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Sarcoidosis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 000 1 250 800
Jan 2016

Bronchiolitis-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Bronchiolitis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Bronchiolitis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and...

1 000 1 250 800
Jan 2016

Chikungunya-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Chikungunya-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Chikungunya. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 000 1 250 800
Jan 2016

Ataxia-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Ataxia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Ataxia. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 000 1 250 800
Jan 2016

Bacteremia-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Bacteremia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Bacteremia. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 000 1 250 800
Jan 2016

Mucositis-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Mucositis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Mucositis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 000 1 250 800
Jan 2016

Spondylitis-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Spondylitis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Spondylitis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 000 1 250 800
Jan 2016

Tauopathies-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Tauopathies-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Tauopathies. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 000 1 250 800
Jan 2016

Hyperoxaluria-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Hyperoxaluria-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hyperoxaluria. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and...

1 000 1 250 800
Jan 2016

Neurofibromatoses-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Neurofibromatoses-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Neurofibromatoses. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase...

1 000 1 250 800
Jan 2016